• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION EKOSONIC KIT 135CM 50CM TZ; CATHETER, CONTINUOUS FLUSH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION EKOSONIC KIT 135CM 50CM TZ; CATHETER, CONTINUOUS FLUSH Back to Search Results
Model Number 500-56150
Device Problems Difficult to Remove (1528); Difficult to Advance (2920); Material Twisted/Bent (2981); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/01/2021
Event Type  malfunction  
Event Description
It was reported that removal difficulty occurred.An ekosonic endovascular device was selected for use during a deep vein subclavian thrombolysis.The infusion catheter was entered through the femoral vein without issue.When the ultrasonic core was advanced it was difficult to advance through the sheath.At this time, the device was then removed and difficultly removing the catheter was also noted.Upon examination post removal, the tip was noted to be kinked.The procedure was completed with another ekosonic catheter.No patient complications were reported.
 
Manufacturer Narrative
The ekos infusion catheter (ic) and ultrasonic core (usc) were returned to boston scientific for analysis.The infusion catheter and usc were inspected for any damage or irregularities.The usc showed signs of use.Kinks were noted 66.2 cm, 100.5 cm and 112.2 cm along the length of the usc.The ic device showed damage in the form of kinks 29.5 cm and under the strain relief.The ic failed the outer diameter ring gage test at 30 cm from the strain relief.Testing was able to pass a in house guidewire through the ic and load the ic through a bend jig but with extreme resistance.The usc was then inserted into the ic and did transcend the catheter but with extreme resistance.Secondary finding of the kink in the infusion catheter is most probably attributable to unintended use error caused or contributed to event.Device analysis determined the condition of the returned device was consistent with the reported information.
 
Event Description
It was reported that removal difficulty occurred.An ekosonic endovascular device was selected for use during a deep vein subclavian thrombolysis.The infusion catheter was entered through the femoral vein without issue.When the ultrasonic core was advanced it was difficult to advance through the sheath.At this time, the device was then removed and difficultly removing the catheter was also noted.Upon examination post removal, the tip was noted to be kinked.The procedure was completed with another ekosonic catheter.No patient complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EKOSONIC KIT 135CM 50CM TZ
Type of Device
CATHETER, CONTINUOUS FLUSH
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key12528966
MDR Text Key273330013
Report Number2134265-2021-11891
Device Sequence Number1
Product Code KRA
UDI-Device Identifier00858593006318
UDI-Public00858593006318
Combination Product (y/n)N
PMA/PMN Number
K182324
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 10/22/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/15/2023
Device Model Number500-56150
Device Catalogue Number500-56150
Device Lot Number0010155057
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/29/2021
Initial Date Manufacturer Received 09/01/2021
Initial Date FDA Received09/24/2021
Supplement Dates Manufacturer Received10/02/2021
Supplement Dates FDA Received10/22/2021
Patient Sequence Number1
-
-